Find trials
Search tips

Non-invasive Treatment for Long COVID Brain Fog

Overview

About this study

This study aims to assess the effects of both acute and chronic exposures to hypoxia and hypercapnia in patients with Long COVID syndrome. 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Individuals will be over the age of 18 and English speaking.
  • All individuals participating will have a Long COVID diagnosis.

Exclusion Criteria:

  • Participants will be excluded if they have known cardiovascular disease including history of coronary artery disease, heart failure, dangerous arrythmias, etc.
  • Individuals who are currently pregnant.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 06/05/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Courtney Wheatley-Guy, Ph.D.

Open for enrollment

Contact information:

Jordan Parks

(480) 301-6616

Parks.Jordan@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20572575

Mayo Clinic Footer